港股異動 | 互聯網醫療板塊拉昇 三部門印發《“十四五”全民健康信息化規劃》
格隆匯11月15日丨阿裏健康漲逾10%,平安好醫生漲約4%。國家衛健委、國家中醫藥局、國家疾控局近日聯合發佈的 《“十四五”全民健康信息化規劃》提出,到2025年,初步建設形成統一權威、互聯互通的全民健康信息平臺支撐保障體系,基本實現公立醫療衛生機構與全民健康信息平臺聯通全覆蓋。《規劃》提出,深化“互聯網+醫療健康”服務體系,完善健康醫療大數據資源要素體系,推進數字健康融合創新發展體系。頂層設計多次提及到互聯網醫療的建設,爲實施健康中國戰略、積極應對人口老齡化戰略、構建優質高效的醫療衛生服務體系提供強力支撐。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.